Viewing Study NCT02476006


Ignite Creation Date: 2025-12-26 @ 4:00 PM
Ignite Modification Date: 2026-02-05 @ 8:57 PM
Study NCT ID: NCT02476006
Status: COMPLETED
Last Update Posted: 2022-03-28
First Post: 2015-06-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
Sponsor: Sanofi
Organization: